Community pharmacist-provided extended diabetes care. - Wikidata - awgldk - TriplyDB

Community pharmacist-provided extended diabetes care.

Community pharmacist-provided extended diabetes care.

http://www.wikidata.org/entity/Q46032913

about

Effectiveness of disease-management programs for improving diabetes care: a meta-analysis Investigating Sources of Heterogeneity in Randomized Controlled Trials of the Effects of Pharmacist Interventions on Glycemic Control in Type 2 Diabetic Patients: A Systematic Review and Meta-Analysis Public perception on the role of community pharmacists in self-medication and self-care in Hong Kong.Care management for Type 2 diabetes in the United States: a systematic review and meta-analysis.The impact of interventions by pharmacists in community pharmacies on control of hypertension: a systematic review and meta-analysis of randomized controlled trials A study protocol: a community pharmacy-based intervention for improving the management of sleep disorders in the community settings.Effectiveness of multidisciplinary intervention on blood pressure control in primary health care: a randomized clinical trial.Clinical delivery of pharmacogenetic testing services: a proposed partnership between genetic counselors and pharmacists.The effect of community pharmacy-based interventions on patient health outcomes: a systematic review.Diabetes and cardiovascular disease interventions by community pharmacists: a systematic review.A systematic review of the evidence for pharmacist care of patients with dyslipidemia.The patient-centered medical home: history, components, and review of the evidence.A review of advances in collaborative pharmacy practice to improve adherence to standards of care in diabetes management.Diabetes Medication Assistance Service Stage 1: impact and sustainability of glycaemic and lipids control in patients with Type 2 diabetes.Pharmacist-Led Self-management Interventions to Improve Diabetes Outcomes. A Systematic Literature Review and Meta-Analysis.Effective Interventions for Diabetes Patients by Community Pharmacists: A Meta-analysis of Pharmaceutical Care Components.Meta-analysis of the effectiveness of chronic care management for diabetes: investigating heterogeneity in outcomes.The Potential for Screening for Intimate Partner Violence in Community Pharmacies: An Exploratory Study of Female Consumers' Perspectives.Efficacy of Pharmacist Based Diabetes Educational Interventions on Clinical Outcomes of Adults With Type 2 Diabetes Mellitus: A Network Meta-Analysis.Effect of a Community Pharmacist–Delivered Diabetes Support Program for Patients Receiving Specialty Medical Care

P2860

Q24630481-245C21B6-3A1E-436E-BBAC-0E352ED73BB9 Q26766537-DB8E329D-357B-4B2C-AD87-8A10EFDB6842 Q34083964-4DD73B01-8F43-4D4E-B5BD-C78FB858731B Q34206991-A4C8EE4C-E90F-498C-B873-926302678F56 Q34635492-686EC5B6-D4DD-485A-8F33-01009D379B19 Q35095957-350E7D0E-449A-40C6-9E29-C61F2703DEEA Q36119110-45A7F996-8586-4F25-B537-65F8F6CBEBCC Q37065155-722006CD-1AA8-4589-9018-6CEF7C807791 Q37120646-FA967AEA-0621-42D4-83B3-5D1F5FE38161 Q37874052-43F52D49-9980-4047-90EB-3AC0C9AC8B77 Q37990847-38F2AA26-EBF0-47B1-94AB-C0A4EBBE097E Q38025591-611516D5-4318-4C61-819B-127AA4D29494 Q38185301-C61CC96C-34BE-4F18-BD1D-06712412BF87 Q39770323-37906920-40D8-4C79-8675-973845184281 Q47170734-602E75EC-4D98-46D5-B92A-189087A283AA Q47921220-FFF4F624-BF9A-45C8-BFA6-795BA0CB88E2 Q50767251-5EDB1B15-5BEC-41B4-8256-71D334C9CCCD Q50961879-E0A23166-BC9B-4AF0-A446-900D0C72CB90 Q52564662-C9F8746B-9F8D-4C31-B9CB-2CA7C4A3436D Q58298992-BA47F422-FF9D-4D8A-9FEE-3CAFF27D332C

P2860

Community pharmacist-provided extended diabetes care.

http://www.wikidata.org/entity/Q46032913

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh-hant

name

Community pharmacist-provided extended diabetes care.

@en

Community pharmacist-provided extended diabetes care.

@nl

type

label

Community pharmacist-provided extended diabetes care.

@en

Community pharmacist-provided extended diabetes care.

@nl

prefLabel

Community pharmacist-provided extended diabetes care.

@en

Community pharmacist-provided extended diabetes care.

@nl

P1433

Q46032913-0791FE84-6512-4D28-9407-C4C9F57D8046

P1476

Q46032913-DE98FEC7-43B4-46C9-AADF-6344054874B3

P2093

Q46032913-5BCE8CFB-B212-4E1F-BB1B-97C48C3C0BEA

Q46032913-609F528F-B822-47BA-9800-F18BB93FABE0

Q46032913-61610300-745D-4C69-BD5B-2FDC1471223D

Q46032913-EEA2848B-A91D-48C4-A838-8DD3B774354A

P2860

Q46032913-00270842-4CBA-4FBD-8D8E-C68D7DA67FD2

Q46032913-133086C1-CEBA-497C-8E9E-93B609D3F0CD

Q46032913-37D4A1A4-3EE3-4681-881F-7229C8CE38E6

Q46032913-3D1BF56A-E217-4658-A855-511A74AAA614

Q46032913-3D55F010-D5D9-46E3-9BB9-E99BA5D6F047

Q46032913-4B17A831-2C8B-4C41-8284-2E24343DC602

Q46032913-544EABF5-AD7A-4CDF-A24B-39029EA036C9

Q46032913-5560ABF4-5CE2-40F7-BB26-6C841C7A799C

Q46032913-57EF322B-7364-4CAC-9398-5D5236DD3FDA

Q46032913-5AFC0F05-0757-488C-9B60-21C304C6E1D0

P304

Q46032913-DD399872-78D9-474D-AEBD-75F726008AC9

P31

Q46032913-542F56B9-3E0F-4111-AAC2-C28C59493351

P356

Q46032913-6139C83B-F663-4DCC-B110-3A13F5F01918

P407

Q46032913-2E9AD6B9-5BFA-4783-BAD1-B7DEA6DA17B3

P433

Q46032913-2707407A-BFE5-4377-847C-07E93F1E979D

P478

Q46032913-59BCB764-B376-4247-862B-8AD95EBCC06D

P577

Q46032913-9BFFD36E-A957-43B5-B6F6-2A20E1BBDC42

P698

Q46032913-52390CBA-C72C-40C3-9FC9-D7095AA9CFB9

P356

P1433

Annals of Pharmacotherapy

P1476

Community pharmacist-provided extended diabetes care.

@en

P2093

Karen B Farris

http://www.w3.org/2001/XMLSchema#string

Matthew J Witry

http://www.w3.org/2001/XMLSchema#string

Randal P McDonough

http://www.w3.org/2001/XMLSchema#string

William R Doucette

http://www.w3.org/2001/XMLSchema#string

P2860

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

Clinical impact of a pharmacist-managed diabetes mellitus drug therapy management service

A randomized trial of a primary care-based disease management program to improve cardiovascular risk factors and glycated hemoglobin levels in patients with diabetes

Effects of intensive glucose lowering in type 2 diabetes

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

Physician counseling about exercise.

The summary of diabetes self-care activities measure: results from 7 studies and a revised scale.

Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program.

Drug therapy management: an empirical report of drug therapy problems, pharmacists' interventions, and results of pharmacists' actions.

P304

882-889

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1345/APH.1L605

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

43

http://www.w3.org/2001/XMLSchema#string

P577

2009-04-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19401477

http://www.w3.org/2001/XMLSchema#string